These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 5161744)

  • 1. [Diagnostic value of some iron metabolic parameters in acute and chronic liver diseases].
    Scuro LA
    Quad Sclavo Diagn; 1971 Dec; 7(4):1302-23. PubMed ID: 5161744
    [No Abstract]   [Full Text] [Related]  

  • 2. Iron mobilisation with chelating agents during acute viral hepatitis.
    Hengeveld P; Zuyderhoudt FM
    Hepatogastroenterology; 1982 Oct; 29(5):191-4. PubMed ID: 7173806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transferrin anomalies in some acute and chronic liver diseases].
    Fiaschi E; Scuro LA; Dobrilla G
    Epatologia; 1969; 15(4):279-94. PubMed ID: 5407546
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of deferoxamine on urinary excretion of iron in chronic non-hemochromatosic liver diseases].
    Brusa L; De Filippi PG; Cravario A
    Boll Soc Ital Biol Sper; 1967 Feb; 43(4):205-9. PubMed ID: 6055647
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on iron metabolism with desferrioxamine in man. Experimental and clinical studies.
    Hedenberg L
    Scand J Haematol Suppl; 1969; 6():5-86. PubMed ID: 5259199
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical usefulness of iron chelating agents.
    Waxman HS; Brown EB
    Prog Hematol; 1969; 6():338-73. PubMed ID: 4976246
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of a prolonged superoxide flux on transferrin and ferritin.
    Paul T
    Arch Biochem Biophys; 2000 Oct; 382(2):253-61. PubMed ID: 11068877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic use of the desferrioxamine B test].
    Pifanelli A; Ferrari R; Cavaliere S; Alboni P
    Riv Patol Clin Sper; 1969; 10(3):215-31. PubMed ID: 5403769
    [No Abstract]   [Full Text] [Related]  

  • 9. The surface of rat hepatocytes can transfer iron from stable chelates to external acceptors.
    Scheiber B; Goldenberg H
    Hepatology; 1998 Apr; 27(4):1075-80. PubMed ID: 9537448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition and treatment of iron overload.
    Brown EB
    Adv Intern Med; 1980; 26():159-86. PubMed ID: 7013439
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mechanism of action of desferrioxamine].
    Kaszewska-Jablońska I; Zielińska W
    Wiad Lek; 1975 Jan; 28(2):89-96. PubMed ID: 1111247
    [No Abstract]   [Full Text] [Related]  

  • 12. Chelator-facilitated removal of iron from transferrin: relevance to combined chelation therapy.
    Devanur LD; Evans RW; Evans PJ; Hider RC
    Biochem J; 2008 Jan; 409(2):439-47. PubMed ID: 17919118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive oxygen metabolite-induced toxicity to cultured bovine endothelial cells: status of cellular iron in mediating injury.
    Hiraishi H; Terano A; Razandi M; Pedram A; Sugimoto T; Harada T; Ivey KJ
    J Cell Physiol; 1994 Jul; 160(1):132-4. PubMed ID: 8021293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis.
    Richardson DR; Ponka P
    J Lab Clin Med; 1994 Nov; 124(5):660-71. PubMed ID: 7964124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Iron metabolism in liver diseases].
    Prieto Valtueña J
    Sangre (Barc); 1982; 27(4-B):604-11. PubMed ID: 7157135
    [No Abstract]   [Full Text] [Related]  

  • 16. Transfusion haemosiderosis and chelation therapy.
    Ley TJ; Griffith P; Nienhuis AW
    Clin Haematol; 1982 Jun; 11(2):437-64. PubMed ID: 7042160
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnostic value of the trace elements and related carrier proteins in chronic liver diseases].
    Cavanna A; Avagnina P; Pecchio F; Brizio T; Armand S; Molino G
    Minerva Dietol Gastroenterol; 1982; 28(4):311-9. PubMed ID: 7167243
    [No Abstract]   [Full Text] [Related]  

  • 18. Removal of non-transferrin-bound iron from blood with iron overload using a device with immobilized desferrioxamine.
    Ambrus CM; Stadler I; Toumbis CA; Stadler A; Anthone S; Anthone R; DeAlarcon P; Deshpande G; Conway J; Vladutiu AO; Ambrus JL
    J Med; 1999; 30(3-4):211-24. PubMed ID: 17312675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic value of determining ceruloplasmin and transferrin in various acute and chronic liver diseases].
    Dzhalalov AD; Maksimov VA
    Ter Arkh; 1982; 54(2):57-9. PubMed ID: 7071774
    [No Abstract]   [Full Text] [Related]  

  • 20. Magnetic resonance imaging and different levels of iron overload in chronic liver disease.
    Rocchi E; Cassanelli M; Borghi A; Paolillo F; Pradelli M; Casalgrandi G; Burani A; Gallo E
    Hepatology; 1993 Jun; 17(6):997-1002. PubMed ID: 8514272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.